BSE Live
Mar 04, 12:25Prev. Close
327.70
Open Price
319.30
Bid Price (Qty.)
318.90 (15)
Offer Price (Qty.)
319.95 (38)
NSE Live
Mar 04, 12:25Prev. Close
326.40
Open Price
332.00
Bid Price (Qty.)
319.15 (29)
Offer Price (Qty.)
319.70 (25)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 12.23 | -9.80 | 20.08 | 22.45 | 10.36 | |
| Diluted EPS (Rs.) | 12.23 | -9.80 | 20.08 | 22.45 | 10.36 | |
| Cash EPS (Rs.) | 18.34 | -1.69 | 24.35 | 26.48 | 12.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 105.81 | 91.34 | 104.23 | 81.52 | 27.16 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 105.81 | 91.34 | 104.23 | 81.52 | 27.16 | |
| Revenue from Operations/Share (Rs.) | 135.70 | 118.64 | 126.39 | 128.52 | 94.91 | |
| PBDIT/Share (Rs.) | 30.14 | 0.42 | 33.01 | 38.48 | 21.80 | |
| PBIT/Share (Rs.) | 22.66 | -7.74 | 28.00 | 34.49 | 19.29 | |
| PBT/Share (Rs.) | 16.91 | -12.96 | 26.26 | 32.17 | 17.23 | |
| Net Profit/Share (Rs.) | 10.83 | -9.88 | 19.31 | 22.45 | 10.36 | |
| NP After MI And SOA / Share (Rs.) | 12.23 | -9.80 | 20.08 | 22.45 | 10.36 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.20 | 0.35 | 26.11 | 29.94 | 22.96 | |
| PBIT Margin (%) | 16.70 | -6.52 | 22.15 | 26.83 | 20.32 | |
| PBT Margin (%) | 12.46 | -10.92 | 20.77 | 25.03 | 18.15 | |
| Net Profit Margin (%) | 7.98 | -8.32 | 15.27 | 17.46 | 10.91 | |
| NP After MI And SOA Margin (%) | 9.00 | -8.26 | 15.88 | 17.46 | 10.91 | |
| Return on Networth/Equity (%) | 11.63 | -10.78 | 19.26 | 27.53 | 38.16 | |
| Return on Capital Employed (%) | 11.78 | -4.16 | 16.50 | 28.50 | 14.52 | |
| Return on Assets (%) | 4.80 | -3.74 | 10.28 | 15.51 | 5.83 | |
| Total Debt/Equity (X) | 1.00 | 1.16 | 0.57 | 0.40 | 3.78 | |
| Asset Turnover Ratio (%) | 53.36 | 45.26 | 64.72 | 88.79 | 53.43 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.81 | 1.52 | 3.57 | 3.30 | 3.02 | |
| Quick Ratio (X) | 0.70 | 0.63 | 2.32 | 1.96 | 2.31 | |
| Inventory Turnover Ratio (X) | 1.98 | 1.76 | 3.93 | 4.04 | 2.99 | |
| Dividend Payout Ratio (NP) (%) | 2.04 | 0.00 | 4.97 | 4.45 | 9.63 | |
| Dividend Payout Ratio (CP) (%) | 1.26 | 0.00 | 3.97 | 3.77 | 7.70 | |
| Earnings Retention Ratio (%) | 97.96 | 0.00 | 95.03 | 95.55 | 90.37 | |
| Cash Earnings Retention Ratio (%) | 98.74 | 0.00 | 96.03 | 96.23 | 92.30 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 3.94 | -1.49 | 16.06 | 14.91 | 9.34 | |
| Interest Coverage Ratios (Post Tax) (%) | 3.94 | -1.49 | 16.06 | 14.91 | 9.34 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,138.45 | 1,025.77 | 2,485.59 | 2,780.20 | 2,432.49 | |
| EV/Net Operating Revenue (X) | 2.36 | 1.29 | 2.94 | 3.29 | 4.48 | |
| EV/EBITDA (X) | 10.62 | 365.25 | 11.27 | 10.98 | 19.52 | |
| MarketCap/Net Operating Revenue (X) | 1.63 | 0.50 | 2.66 | 3.23 | 4.06 | |
| Retention Ratios (%) | 97.95 | 0.00 | 95.02 | 95.54 | 90.36 | |
| Price/BV (X) | 2.10 | 0.65 | 3.22 | 5.10 | 14.17 | |
| Price/Net Operating Revenue | 1.63 | 0.50 | 2.66 | 3.23 | 4.06 | |
| Earnings Yield | 0.06 | -0.17 | 0.06 | 0.05 | 0.03 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y